GaLV pseudotyped vectors and cationic lipids transduce human CD34+ cells

Human Gene Therapy

Volumn 8, Issue 14, 1997, Pages 1685-1694

  Dybing, Jennifer ^a  

^a Targeted Genetics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; HEXADIMETHRINE BROMIDE; LIPID; POLYCATION; PROTAMINE SULFATE; VIRUS VECTOR;

ARTICLE; BONE MARROW CELL; GENE THERAPY; GENETIC DISORDER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NONHUMAN; RETROVIRUS; TRANSGENE;

EID: 0031580713     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.14-1685     Document Type: Article

References (3)

1. + cells with a human immunodeficiency virus type-1 based retroviral vector pseudotyped with Vesicular Stomatitis Virus envelope by glycoprotein G. J. Virol. 70, 2581-2585.
2. BALASUBRAMANIAN, R.P., BENNETT, M., ABERLE, A., MALONE, J.G., NANTZ, M., and MALONE, R.W. (1996). Structural and functional analysis of cationic transfection lipids: The Hydrophobic domain. Gene Therapy 3, 163-172.
3. + hematopoietic cell transduction with cell-free retroviral vector preparations. Proc. Natl. Acad. Sci. USA 92, 4372-4376.